article thumbnail

Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares

Lloyd Price

2004: First GLP-1 receptor agonist (GLP-1 RA), exenatide, approved for type 2 diabetes treatment. Drug development: Pharmaceutical companies like Novo Nordisk, Eli Lilly, and AstraZeneca led the development and commercialization of GLP-1 RAs. 1996: Studies suggest GLP-1's potential in managing type 2 diabetes and obesity.

article thumbnail

Linden Announces Agreement to Acquire Majority Stake in Aspirion from Aquiline Capital Partners

Healthcare IT Today

Founded in 2004, Linden is one of the country’s largest dedicated healthcare private equity firms. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. About Linden Capital Partners.

RCM 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FemTech M&A: What’s driving FemTech’s growth?

Lloyd Price

Femtech products and services can range from wearable devices, mobile apps, and online platforms to diagnostic tools, medical devices, and pharmaceuticals. Natera - a genetic testing and diagnostics company that was founded in 2004, went public on July 1, 2015. What’s driving FemTech’s growth? Billion latest valuation.

article thumbnail

Diasome’s Liver Targeted Insulin

Insulin Nation

Robert Geho, CEO of Diasome Pharmaceuticals, Inc. We spoke with Robert Geho, CEO of Diasome Pharmaceuticals, Inc. Diasome was founded in 2004 and has raised multiple rounds of funding, including support from the JDRF T1D Fund in Boston. Normal vs Injected Insulin. The most recent funding was in October 2018.

article thumbnail

Scotland's Pioneering Spirit: A Legacy of Medical and Healthcare Innovation

Lloyd Price

The top three sectors for investment were: Digital health (£244 million) Therapeutics (£225 million) Medtech (£136 million) Some of the notable deals in 2022 included: Amphista Therapeutics (£38 million) Resolution Therapeutics (£34 million) ODx (£7.6

article thumbnail

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

And PLM did business deals with large pharmaceutical companies who wanted the data to advance their research and development efforts – that’s how the PLM business was primarily funded. Fear about an Ever-Changing Context : When PLM first formed back in 2004, a lot of the data sharing issues we speak about hadn’t even been conceived of yet.

article thumbnail

150 top places to work in healthcare

Henry Kotula

Launched in 2004, Medicus Healthcare Solutions provides locum tenens staffing to practices, hospitals and healthcare organizations across the country. As an integrated healthcare services and product company, Cardinal provides medical products, pharmaceuticals and cost-effective supply chain solutions across the healthcare delivery spectrum.